| [1] |
Chen-Xu M, Yokose C, Rai SK, et al. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: The National Health and Nutrition Examination Survey, 2007-2016[J]. Arthritis Rheumatol, 2019, 71(6):991-999.
|
| [2] |
Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: A systematic review and meta-analysis[J]. Biomed Res Int, 2015, 2015:762820.
|
| [3] |
Li Y, Shen Z, Zhu B, et al. Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: A systematic review and meta-analysis[J]. Glob Health Action, 2021, 14(1):1874652.
|
| [4] |
Jun JE, Lee YB, Lee SE, et al. Elevated serum uric acid predicts the development of moderate coronary artery calcification independent of conventional cardiovascular risk factors[J]. Atherosclerosis, 2018, 272:233-239.
|
| [5] |
Kiss LZ, Bagyura Z, Csobay-Novák C, et al. Serum uric acid is independently associated with coronary calcification in an asymptomatic population[J]. J Cardiovasc Transl Res, 2019, 12(3):204-210.
|
| [6] |
Liang L, Hou X, Bainey KR, et al. The association between hyperuricemia and coronary artery calcification development: A systematic review and meta-analysis[J]. Clin Cardiol, 2019, 42(11):1079-1086.
|
| [7] |
Wang X, Liu X, Qi Y, et al. High level of serum uric acid induced monocyte inflammation is related to coronary calcium deposition in the middle-aged and elder population of China: A five-year prospective cohort study[J]. J Inflamm Res, 2022, 15:1859-1872.
|
| [8] |
Luis-Rodríguez D, Donate-Correa J, Martín-Núñez E, et al. Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia[J]. Rheumatology (Oxford), 2021, 60(1):371-379.
|
| [9] |
Agrawal M, Niroula A, Cunin P, et al. TET2-mutant clonal hematopoiesis and risk of gout[J]. Blood, 2022,140(10):1094-1103.
|
| [10] |
Doğru S, Yaşar E, Yeşilkaya A. Uric acid can enhance MAPK pathway-mediated proliferation in rat primary vascular smooth muscle cells via controlling of mitochondria and caspase-dependent cell death[J]. J Recept Signal Transduct Res, 2022, 42(3):293-301.
|
| [11] |
Kimura Y, Yanagida T, Onda A, et al. Soluble uric acid promotes atherosclerosis via ampk (amp-activated protein kinase)-mediated inflammation[J]. Arterioscler Thromb Vasc Biol, 2020, 40(3):570-582.
|
| [12] |
Chen M, Lu X, Lu C, et al. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway[J]. Arthritis Res Ther, 2018,20(1):20.
|
| [13] |
Roumeliotis S, Roumeliotis A, Dounousi E, et al. Dietary antioxidant supplements and uric acid in chronic kidney disease: A review[J]. Nutrients, 2019, 11(8):1911.
|
| [14] |
Song C, Zhao X. Uric acid promotes oxidative stress and enhances vascular endothelial cell apoptosis in rats with middle cerebral artery occlusion[J]. Biosci Rep, 2018, 38(3):BSR20170939.
|
| [15] |
Borghi C, Rosei EA, Bardin T, et al. Serum uric acid and the risk of cardiovascular and renal disease[J]. J Hypertens, 2015, 33(9):1729-1741.
|
| [16] |
Yuan H, Yu C, Li X, et al. Serum uric acid levels and risk of metabolic syndrome: A dose-response meta-analysis of prospective studies[J]. J Clin Endocrinol Metab, 2015, 100(11):4198-4207.
|
| [17] |
Wang J, Qin T, Chen J, et al. Hyperuricemia and risk of incident hypertension: A systematic review and meta-analysis of observational studies[J/OL]. PLoS One, 2014, 9(12):e114259.
|
| [18] |
Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies[J/OL]. PLoS One, 2013, 8(2):e56864.
|
| [19] |
Maloberti A, Biolcati M, Ruzzenenti G, et al. The role of uric acid in acute and chronic coronary syndromes[J]. J Clin Med, 2021,10(20):4750.
|
| [20] |
White J, Sofat R, Hemani G, et al. Plasma urate concentration and risk of coronary heart disease: A Mendelian randomisation analysis[J]. Lancet Diabetes Endocrinol, 2016, 4(4):327-336.
|
| [21] |
Kleber ME, Delgado G, Grammer TB, et al. Uric acid and cardiovascular events: A mendelian randomization study[J]. J Am Soc Nephrol, 2015, 26(11):2831-2838.
|
| [22] |
Borghi C, Domienik-Karłowicz J, Tykarski A, et al. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update[J]. Cardiol J, 2021, 28(1):1-14.
|